LEFLUNOMIDE IN EARLY RHEUMATOID ARTHRITIS: INCLUSION IN THE TREATMENT STRATEGY AND PROSPECTS
According to the literature, Leflunomide is comparable in efficacy and safety with methotrexate, including patients with early rheumatoid arthritis (RA). The drug continues to play an important role in the treatment of patients with early RA and may be considered as a main synthetic base anti-inflam...
| Published in: | Медицинский совет |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2017-12-01
|
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1667 |